These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 10605465)

  • 21. [Treatment for viral respiratory infections: Principles of action, strategies, and future prospects].
    Rohde G; Schultze-Werninghaus G; Bauer TT
    Internist (Berl); 2004 Apr; 45(4):468-75. PubMed ID: 15021931
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new antiviral agent for influenza--is there a clinical niche?
    Couch RB
    N Engl J Med; 1997 Sep; 337(13):927-8. PubMed ID: 9302309
    [No Abstract]   [Full Text] [Related]  

  • 23. [Oral neuraminidase inhibitor and an early warning system. New weapons against influenza].
    Lange W; Vogel GE
    MMW Fortschr Med; 2003 Jan; 145(3-4):36-7. PubMed ID: 12619232
    [No Abstract]   [Full Text] [Related]  

  • 24. Neuraminidase inhibitors slightly beneficial for shortening flu symptoms.
    Phillips TG
    J Fam Pract; 2003 Oct; 52(10):747-8. PubMed ID: 14529590
    [No Abstract]   [Full Text] [Related]  

  • 25. Zanamivir: an influenza virus neuraminidase inhibitor.
    Colman PM
    Expert Rev Anti Infect Ther; 2005 Apr; 3(2):191-9. PubMed ID: 15918777
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug under test: influenza--Relenza in daily practice. Experience during the influenza season 1999/2000.
    Schmidt RE
    Med Microbiol Immunol; 2002 Dec; 191(3-4):175-9. PubMed ID: 12458355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Neuraminidase inhibitors oseltamivir and zanamivir: new means of defence against influenza].
    de Jong JC; Beyer WE; Rimmelzwaan GF; Fouchier RA; Osterhaus AD
    Ned Tijdschr Geneeskd; 2004 Jan; 148(2):73-9. PubMed ID: 14753128
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuraminidase inhibitors in the management of influenza--experience of an outpatient practice.
    Vogel GE
    Med Microbiol Immunol; 2002 Dec; 191(3-4):161-3. PubMed ID: 12458352
    [TBL] [Abstract][Full Text] [Related]  

  • 29. We need to determine who benefits most from flu treatments.
    Hansen L
    BMJ; 2003 Jun; 326(7401):1239-40. PubMed ID: 12791736
    [No Abstract]   [Full Text] [Related]  

  • 30. Neuraminidase inhibitors for influenza.
    Moscona A
    N Engl J Med; 2005 Sep; 353(13):1363-73. PubMed ID: 16192481
    [No Abstract]   [Full Text] [Related]  

  • 31. Flu drugs. Have I got news for flu.
    Snell J
    Health Serv J; 2000 Jan; 110(5689):suppl 5. PubMed ID: 11184398
    [No Abstract]   [Full Text] [Related]  

  • 32. The relentless flu drug.
    Environ Health Perspect; 1998 Aug; 106(8):A372-3. PubMed ID: 9867459
    [No Abstract]   [Full Text] [Related]  

  • 33. Zanamivir: an update of its use in influenza.
    Cheer SM; Wagstaff AJ
    Drugs; 2002; 62(1):71-106. PubMed ID: 11790157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of the neuraminidase inhibitor zanamivirin the treatment of influenza A and B virus infections.
    Monto AS; Fleming DM; Henry D; de Groot R; Makela M; Klein T; Elliott M; Keene ON; Man CY
    J Infect Dis; 1999 Aug; 180(2):254-61. PubMed ID: 10395837
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Randomised trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infections. The MIST (Management of Influenza in the Southern Hemisphere Trialists) Study Group.
    Lancet; 1998 Dec; 352(9144):1877-81. PubMed ID: 9863784
    [TBL] [Abstract][Full Text] [Related]  

  • 36. UK government not convinced by claims for flu drug.
    Loder N
    Nature; 1999 Oct; 401(6754):631. PubMed ID: 10537096
    [No Abstract]   [Full Text] [Related]  

  • 37. [Neuraminidase inhibitor permitted. The first pill against influenza].
    MMW Fortschr Med; 2002 Oct; 144(41):56. PubMed ID: 12474367
    [No Abstract]   [Full Text] [Related]  

  • 38. Two neuraminidase inhibitors for treatment of influenza.
    Med Lett Drugs Ther; 1999 Oct; 41(1063):91-3. PubMed ID: 10535051
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical efficacy and safety of the orally inhaled neuraminidase inhibitor zanamivir in the treatment of influenza: a randomized, double-blind, placebo-controlled European study.
    Mäkelä MJ; Pauksens K; Rostila T; Fleming DM; Man CY; Keene ON; Webster A
    J Infect; 2000 Jan; 40(1):42-8. PubMed ID: 10762110
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Zanamivir, influenza, and meningococcal disease. Zanamivir may help to fight potential flu epidemic.
    Green ST
    BMJ; 2000 Feb; 320(7231):378. PubMed ID: 10657343
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.